Michael Rigney is a Senior Executive Oncology Specialist at AstraZeneca, where they have developed expertise in strategic thinking, technical selling, and leadership since joining in 2015. Previously, they served as a Market Development Specialist at Onyx Pharmaceuticals from 2009 to 2015, focusing on expanding the prescriber base for unresectable Hepatocellular Carcinoma. Michael has also worked as a Senior Specialty Representative at Schering-Plough, specializing in oncology and hepatology. They are currently enrolled in Amgen's Management Development Program, which aims to hone their management skills in coaching, communication, and talent evaluation. Michael holds a B.S. in Finance from Penn State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices